Skip to main content

Table 1 Characterizations of the liposomes

From: Irinotecan/scFv co-loaded liposomes coaction on tumor cells and CAFs for enhanced colorectal cancer therapy

 

DLS (nm)

PDI

Zeta potential (mV)

EE (%)

LE (%)

IRI-Lip

138.3 ± 2.0

0.13 ± 0.03

− 16.7 ± 0.3

90.4 ± 2.0

8.7 ± 1.3

IRI-RGD-Lip

141.7 ± 0.6

0.11 ± 0.02

− 16.5 ± 2.0

97.4 ± 3.3

9.9 ± 0.3

IRI-RGD/R9-Lip

125.1 ± 2.8

0.16 ± 0.02

 + 6.3 ± 0.3

100.2 ± 5.9

8.9 ± 0.5

IRI-RGD/R9-sLip

126.8 ± 2.6

0.19 ± 0.02

− 3.3 ± 0.4

98.0 ± 2.0

8.7 ± 0.1